StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Rekah Pharmaceutical Industry Ltd.
Tel Aviv Stock Exchange:REKA.TA
Sector
Location
Market Cap
USD 42.37 M
Share Price
USD 3.57
Avg Daily Volume
3,106
Change (1 day)
-1.65%
Change (1 year)
-17.73%
Change (YTD)
-3.02%
Rekah Pharmaceutical Industry Ltd. Accounts Payable for the year ending December 31, 2024: USD 26.50 M
Rekah Pharmaceutical Industry Ltd. Accounts Payable is USD 26.50 M for the year ending December 31, 2024, a 21.98% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Rekah Pharmaceutical Industry Ltd. Accounts Payable for the year ending December 31, 2023 was USD 21.73 M, a -13.22% change year over year.
-
Rekah Pharmaceutical Industry Ltd. Accounts Payable for the year ending December 31, 2022 was USD 25.04 M, a 26.93% change year over year.
-
Rekah Pharmaceutical Industry Ltd. Accounts Payable for the year ending December 31, 2021 was USD 19.73 M, a -0.59% change year over year.
-
Rekah Pharmaceutical Industry Ltd. Accounts Payable for the year ending December 31, 2020 was USD 19.84 M, a 39.81% change year over year.
Competitors
Johnson & Johnson
USD 163.70
JNJ
+0.72
0.44%
Divi's Laboratories Limited
USD 78.11
DIVISLAB.NS
-0.76
-0.96%
ALK-Abelló A/S
USD 30.16
ALK-B.CO
+0.09
0.29%
Nahdi Medical Company
USD 34.79
4164.SR
+0.18
0.53%
Rohto Pharmaceutical Co.,Ltd.
USD 13.91
4527.T
-0.12
-0.88%
Hypera S.A.
USD 4.72
HYPE3.SA
-0.08
-1.71%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.19
JBCHEPHARM.NS
-0.13
-0.69%
Almirall, S.A.
USD 12.44
ALM.MC
+0.06
0.45%
Organon & Co.
USD 9.46
OGN
-0.18
-1.87%
Dermapharm Holding SE
USD 39.87
DMP.DE
-0.24
-0.61%
Caplin Point Laboratories Limited
USD 24.41
CAPLIPOINT.NS
-0.10
-0.39%
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Johnson & Johnson
USD 163.70
JNJ
+0.72
0.44%
Divi's Laboratories Limited
USD 78.11
DIVISLAB.NS
-0.76
-0.96%
ALK-Abelló A/S
USD 30.16
ALK-B.CO
+0.09
0.29%
Nahdi Medical Company
USD 34.79
4164.SR
+0.18
0.53%
Rohto Pharmaceutical Co.,Ltd.
USD 13.91
4527.T
-0.12
-0.88%
Hypera S.A.
USD 4.72
HYPE3.SA
-0.08
-1.71%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.19
JBCHEPHARM.NS
-0.13
-0.69%
Almirall, S.A.
USD 12.44
ALM.MC
+0.06
0.45%
Organon & Co.
USD 9.46
OGN
-0.18
-1.87%
Dermapharm Holding SE
USD 39.87
DMP.DE
-0.24
-0.61%
Caplin Point Laboratories Limited
USD 24.41
CAPLIPOINT.NS
-0.10
-0.39%
Eli Lilly and Company
USD 771.71
LLY
+10.21
1.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
AstraZeneca PLC
USD 138.02
AZN.L
-0.31
-0.22%
Merck & Co., Inc.
USD 79.96
MRK
-1.56
-1.91%
Amgen Inc.
USD 294.76
AMGN
-3.49
-1.17%
Pfizer Inc.
USD 24.47
PFE
-0.11
-0.45%
Gilead Sciences, Inc.
USD 108.22
GILD
-0.58
-0.53%